
---
title: '8月30日龙虎榜解析：爱康科技净买入额最多，还有39只个股被机构扫货'
categories: 
 - 金融
 - 每经网
 - 分类
headimg: 'https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/4ad51afdcba24538b381eda30bfe2777?nbddata-height=1182&nbddata-width=900'
author: 每经网
comments: false
date: Mon, 30 Aug 2021 17:13:44 GMT
thumbnail: 'https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/4ad51afdcba24538b381eda30bfe2777?nbddata-height=1182&nbddata-width=900'
---

<div>   
<p><span style="font-weight: bold;">每经AI快讯，</span><span>8月30日，共有308只个股上榜龙虎榜，爱康科技龙虎榜净买入额最多，达4.27亿元。</span></p>
<p style="line-height: 1.6; margin-bottom: 15px;"><img src="https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/4ad51afdcba24538b381eda30bfe2777?nbddata-height=1182&nbddata-width=900" alt width="100%" referrerpolicy="no-referrer"></p>
<p>在龙虎榜中，涉及机构专用席位的个股有39只，净买入额前三的是西藏珠峰、赣锋锂业、卫 士 通，分别为1.07亿元、1.04亿元、1.03亿元。</p>
<p style="line-height: 1.6; margin-bottom: 15px;"><img src="https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/372dda9fae32481e8f23ed896958fe12?nbddata-height=1182&nbddata-width=900" alt width="100%" referrerpolicy="no-referrer"></p>
<p>在龙虎榜中，涉及沪股通专用席位的个股有5只，东方证券的沪股通专用席位净买入额最大，净买入1804.9万元。</p>
<p style="line-height: 1.6; margin-bottom: 15px;"><img src="https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/848ee578ac4445ec84cf4130181fe8dd?nbddata-height=702&nbddata-width=900" alt width="100%" referrerpolicy="no-referrer"></p>
<p>在龙虎榜中，涉及深股通专用席位的个股有13只，中泰化学的深股通专用席位净买入额最大，净买入1.64亿元。</p>
<p style="line-height: 1.6; margin-bottom: 15px;"><img src="https://nbd-writer-1252627319.cos.ap-shanghai.myqcloud.com/73b20361e9c34822bc061898adab02fa?nbddata-height=1182&nbddata-width=900" alt width="100%" referrerpolicy="no-referrer"></p>
<p class="m-original-right" style="width: 100%; text-align: right; font-weight: bold;">(记者 姚祥云)</p>
<p class="nbd-mzsm" style="line-height: 1.6; margin-bottom: 15px; font-size: 18px; color: red;">免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。</p>

        <!-- 当没有勾选文章中显示缩略图时，在文章最末尾加上 封面图片来源：摄图网 -->


        <!-- 页数 -->
        
</div>
            